참고문헌
- Eytan GD. Mechanism of multidrug resistance in relation to passive membrane permeation. Biomed Pharmacother 2005;59:90-7 https://doi.org/10.1016/j.biopha.2005.01.003
- Galina R, Jocelyne P, Sharom FJ. P-Glycoprotein is localized in intermediate-density membrane microdomains distinct from classical lipid rafts and caveolar domains. FEBS Journal 2005;272:4924-37 https://doi.org/10.1111/j.1742-4658.2005.04905.x
- Mahadevan D, List AF. Targeting the multidrug resistance-1 transporter inAML: molecular regulation and therapeutic strategies. Blood 2004;104:1940-51 https://doi.org/10.1182/blood-2003-07-2490
- Stierle V, Laigle A, Jolle B. Modulation of MDR1 gene expression in multidrug resistant MCF7 cells by low concentrations of small interfering RNAs. Biochemical Pharmacology 2005;70:1424-30 https://doi.org/10.1016/j.bcp.2005.08.007
- Matsui Y, Kobayashi N, Nishikawa M, Takakura Y. Sequence-specific suppression of mdr1a/1b expression in mice via RNA interference. Pharmaceutical Research 2005;22:2091-98 https://doi.org/10.1007/s11095-005-8178-8
- Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Advanced Drug Delivery Reviews 2003;55:3-29 https://doi.org/10.1016/S0169-409X(02)00169-2
- Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Craig CM. Potent and specific genetic interference by double stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-11 https://doi.org/10.1038/35888
- Hannon GJ. RNA interference. Nature 2002;418:244-51 https://doi.org/10.1038/418244a
- Wu H, Hait W, Yang JM. Small interfering RNA-induced suppression of MDR1 (P-Glycoprotein) restores sensitivity to multidrug-resistant cancer cells. Cancer Res 2003;63:1515-19
- Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 1999;141:443-57 https://doi.org/10.1530/eje.0.1410443
- Chung JK. Sodium Iodide Symporter: Its role in nuclear medicine. J Nucl Med 2002;43:1188-200
- Levy O, Vieja AD, Carrasco N. The Na+/I- Symporter (NIS): recent advances. J Bioenerg Biomembr 1998;30:195-206 https://doi.org/10.1023/A:1020577426732
- Lee YJ, Chung JK, Shin JH, Kang JH, Jeong JM, Lee DS et al. In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene. Thyroid 2004;14;889-95 https://doi.org/10.1089/thy.2004.14.889
- Miyagawa M, Anton M, Wagner B, Haubner R, Souvatzoglou M, Gansbacher B, et al. Non-invasive imaging of cardiac transgene expression with PET: comparison of the human sodium/iodide symporter gene and HSV1-tk as the reporter gene. Eur J Nucl Med Mol Imaging 2005;32:1108-14 https://doi.org/10.1007/s00259-005-1854-4
- Lee KH, Kim HK, Paik JY, Matsui T, Choe YS, Choi Y, et al. Accuracy of myocardial sodium/iodide symporter gene expression imaging with radioiodide: evaluation with a dual-gene adenovirus vector. J Nucl Med 2005;46:652-7
- Spitzweg C, Dietz AB, O'Connor MK, Bergert ER, Tindall DJ, Young CYF, et al. In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Therapy 2001;8:1524-31 https://doi.org/10.1038/sj.gt.3301558
- Boland A, Ricard M, Opolon P, Bidart JM, Patrice Y, Filetti S, et al. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Cancer Res 2000;60:3484-92
- Chung JK, Kang JH. Translational research using the sodium/iodide symporter in imaging and therapy. Eur J Nucl Med Mol Imaging 2004;31:799-802 https://doi.org/10.1007/s00259-004-1475-3
- Kinuya S, Yokoyama K, Fukuoka M, Mori H, Shib K, Watanabe N, et al. Anti-angiogenic therapy and chemotherapy affect 99mTc sestamibi and 99mTc-HL91 accumulation differently in tumour xenografts. Nucl Med Commun 2005;26:1067-73 https://doi.org/10.1097/00006231-200512000-00004
- Rebbaa A, Zheng X, Chou PM, Mirkin BL. Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene 2003;22:2805-11 https://doi.org/10.1038/sj.onc.1206366
- Kamiya H, Tsuchiya H, Yamazaki J, Harashima H. Intracellular trafficking and transgene expression of viral and non-viral gene vectors. Adv Drug Deliv Rev 2001;52:153-64 https://doi.org/10.1016/S0169-409X(01)00216-2
- Young LS, Searle PF, Onion D, Mautner V. Viral gene therapy strategies: from basic science to clinical application. J Pathol 2006;208:299-318 https://doi.org/10.1002/path.1896
- Takara K, Obata Y, Yoshikawa E, Kitada N, Sakaeda T, Ohnishi N, et al. Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel. Cancer Chemother Pharmacol 2006;22
- Burak Z, Moretti JL, Ersoy O, San U, Kantar M, Tamgac F, et al. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance.associated protein and P-glycoprotein expression. J Nucl Med 2003;44: 1394-401
- Jekerle V, Wang JH, Scollard DA, Reilly RM, Wiese M, Micheline PM. 99mTc-Sestamibi, A sensitive probe for in vivo imaging of P-glycoprotein inhibition by modulators and mdr1 antisense oligodeoxynucleotides. Mol Imaging Biol 2006;13:60-6
- Lee J, Ahn BC. Detection of multidrug resistance using molecular nuclear technique. Korean J Nucl Med 2004;38:180-9
-
Yoo JA, Chung SY, Seo MR, Kwak DS, Ahn BC, Lee KB, Lee J. Comparison of the uptakes of
$^{99m}$ Tc-sestamibi and$^{99m}$ Tc-tetrofosmin in cancer cell lines expressiong multidrug resistance. Korean J Nucl Med 2003;37:178-89 - Liu Z, Stevenson GD, Barrett HH, Kastis GA, Bettan M, Furenlid LR, et al. 99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice. Nucl Med Commun 2004;25:711-20 https://doi.org/10.1097/01.mnm.0000130243.06821.90
- Morettil JL, Hauet1 N, Caglar M, Rebillard O, Burak Z. To use MIBI or not to use MIBI? That is the question when assessing tumour cells. Eur J Nucl Med Mol Imaging 2005;32:836-42 https://doi.org/10.1007/s00259-005-1840-x
- Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC. Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice. Gene Therapy 2006;13:60-6 https://doi.org/10.1038/sj.gt.3302599
- Yaghoubi SS, Wu L, Liang Q, Toyokuni T, Barrio JR, Gambhir SS, et al. Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors. Gene Therapy 2001;8:1072-80 https://doi.org/10.1038/sj.gt.3301490
- Tjuvajev JG, Joshi A, Callegari J, Lindsley L, Joshi R, Blasberg RG. A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. Neoplasia 1999;1:315-20 https://doi.org/10.1038/sj.neo.7900053
- Yu Y, Annala AJ, Barrio JR, Toyokuni T, Satyamurthy N, Gambhir SS. Quantification of target gene expression by imaging reporter gene expression in living animals. Nat Med 2000;6:933-7 https://doi.org/10.1038/78704
- Baron U, Freundlieb S, Gossen M, Bujard H. Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 1995;23:3605-6 https://doi.org/10.1093/nar/23.17.3605
- Bramson J, Hitt M, Gallichan WS, Rosenthal KL, Gauldie J, Graham FL. Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12. Hum Gene Therapy 1996;7:333-42 https://doi.org/10.1089/hum.1996.7.3-333
- Wood M, Perrotte P, Onishi E, Harper ME, Dinney C, Pagliaro L, et al. Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse. Cancer Gene Ther 1999;6:367-372 https://doi.org/10.1038/sj.cgt.7700090
- Hemminki A, Belousova N, Zinn KR, Liu B, Wang M, Chaudhuri TR, et al. An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imagingof gene expression. Mol Ther 2001;4:223-231 https://doi.org/10.1006/mthe.2001.0446
- Glasgow JN, Everts M, Curiel DT. Transductional targeting of adenovirus vectors for gene therapy. Cancer Gene Ther 2006; 13:830-844 https://doi.org/10.1038/sj.cgt.7700928